Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-31

Clinical Trial Update: An Exploratory Study on NK Cell-assisted Prevention of Bone Marrow Suppression During Chemotherapy for Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

An exploratory Phase 1/2 trial evaluating whether NK cell–assisted therapy can prevent chemotherapy-induced bone marrow suppression in ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Natural Killer cell therapy (natural killer cell therapy)

Snippet

Sponsor: Anhui Provincial Cancer Hospital | Conditions: Ovary Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING